Companies in the News

This quiet biotech is looking for curative therapies and new vaccines for a host of infectious diseases with an experienced biopharma executive team.

CEO:  George Scangos
Based:  San Francisco
Founded: 2017
Clinical focus: Infectious diseases

The scoop: When George Scangos stepped down as CEO of Biogen in l...

9.26.2017

Emeryville, CA, September 26, 2017 – Gritstone Oncology, a next-generation personalized cancer immunotherapy company, has been named by FierceBiotech as one of 2017’s Fierce 15 biotechnology companies, recognizing it as one of the most promising private biotechnology companies in the industry.

Founded in O...

9.26.2017

BlackThorn Therapeutics has been selected as one of the “Fierce 15” winners for 2017. With this designation, BlackThorn is considered one of the “up-and-coming privately-held biotech companies expected to make big waves in the industry.” The annual Fierce 15 list celebrates the spirit of being “fierce” –...

9.26.2017

Boston-based Indigo announced Tuesday the first closing of $156 million in its Series D financing, doubling the company’s total capital raised to over $300 million. 

Since the latest round now has Indigo valued at $1.4 billion, according to a company spokesperson, the agriculture startup is officially Bost...

9.7.2017

Proceeds Will Support Further Development of Proprietary Tumor Antigen Identification Platform and Advancement of Pipeline of Personalized Cancer Immunotherapies
 

Lead Program Expected to Enter Clinical Trials in Mid-2018
 

Personalized Immunotherapy Manufacturing Facility Under Construction and will Provi...

Please reload